In vitro and in vivo characterization of PF‐04418948, a novel, potent and selective prostaglandin EP2 receptor antagonist

BACKGROUND AND PURPOSE Studies of the role of the prostaglandin EP2 receptor) have been limited by the availability of potent and selective antagonist tools. Here we describe the in vitro/in vivo pharmacological characterization of a novel EP2 receptor antagonist, PF‐04418948 (1‐(4‐fluorobenzoyl)‐3‐{[(6‐methoxy‐2‐naphthyl)oxy]methyl} azetidine‐3‐carboxylic acid).

[1]  Guide to Receptors and Channels (GRAC), 4th edition , 2009, British journal of pharmacology.

[2]  K. Stefánsson,et al.  Antagonists of the EP3 receptor for prostaglandin E2 are novel antiplatelet agents that do not prolong bleeding. , 2009, ACS chemical biology.

[3]  C. Routledge,et al.  BGC20‐1531, a novel, potent and selective prostanoid EP4 receptor antagonist: a putative new treatment for migraine headache , 2009, British journal of pharmacology.

[4]  A. Naylor,et al.  Non-acidic pyrazole EP1 receptor antagonists with in vivo analgesic efficacy. , 2008, Bioorganic & medicinal chemistry letters.

[5]  J A Peters,et al.  Guide to Receptors and Channels (GRAC), 3rd edition , 2008, British journal of pharmacology.

[6]  Kazunari Nakao,et al.  In vitro pharmacological characterization of CJ-042794, a novel, potent, and selective prostaglandin EP(4) receptor antagonist. , 2008, Life sciences.

[7]  S. Narumiya,et al.  Prostaglandin E Receptors* , 2007, Journal of Biological Chemistry.

[8]  M. Toda,et al.  Further optimization of sulfonamide analogs as EP1 receptor antagonists: synthesis and evaluation of bioisosteres for the carboxylic acid group. , 2006, Bioorganic & medicinal chemistry.

[9]  J. Cracowski,et al.  Prostanoids contribute to cutaneous active vasodilation in humans. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[10]  B. Koller,et al.  Receptors and pathways mediating the effects of prostaglandin E2 on airway tone. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[11]  L. Janssen,et al.  Receptors and signaling pathway underlying relaxations to isoprostanes in canine and porcine airway smooth muscle. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[12]  Y. Sugimoto,et al.  Possible coupling of prostaglandin E receptor EP(1) to TRP5 expressed in Xenopus laevis oocytes. , 2002, Biochemical and biophysical research communications.

[13]  Y. Sugimoto,et al.  Prostanoid receptor subtypes. , 2002, Prostaglandins & other lipid mediators.

[14]  S. Narumiya,et al.  Function of prostanoid receptors: studies on knockout mice. , 2002, Prostaglandins & other lipid mediators.

[15]  M. Schmelz,et al.  Prostaglandin E2 induces vasodilation and pruritus, but no protein extravasation in atopic dermatitis and controls. , 2002, Journal of the American Academy of Dermatology.

[16]  D. Crankshaw,et al.  Variable responses to prostaglandin E(2) in human non-pregnant myometrium. , 2001, European journal of pharmacology.

[17]  Y. Boie,et al.  The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. , 2000, Biochimica et biophysica acta.

[18]  D. Crankshaw,et al.  Inhibitory prostanoid EP receptors in human non-pregnant myometrium. , 1999, European journal of pharmacology.

[19]  S. Narumiya,et al.  Prostanoid receptors: structures, properties, and functions. , 1999, Physiological reviews.

[20]  K. Racké,et al.  Prostanoid receptors of the EP3 subtype mediate inhibition of evoked [3H]acetylcholine release from isolated human bronchi , 1998, British journal of pharmacology.

[21]  M. Belvisi,et al.  Prostaglandin E2 suppression of acetylcholine release from parasympathetic nerves innervating guinea‐pig trachea by interacting with prostanoid receptors of the EP3‐subtype , 1998, British journal of pharmacology.

[22]  M. Lew,et al.  Analysis of competitive agonist-antagonist interactions by nonlinear regression. , 1995, Trends in pharmacological sciences.

[23]  Y. Boie,et al.  Molecular Cloning and Characterization of the Human Prostanoid DP Receptor (*) , 1995, The Journal of Biological Chemistry.

[24]  N. E. Robinson,et al.  PGE2 inhibits acetylcholine release from cholinergic nerves in canine but not equine airways. , 1994, Prostaglandins, leukotrienes, and essential fatty acids.

[25]  J. Regan,et al.  Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype. , 1994, Molecular pharmacology.

[26]  K. Metters,et al.  Cloning, functional expression, and characterization of the human prostaglandin E2 receptor EP2 subtype. , 1994, The Journal of biological chemistry.

[27]  I. Pavord,et al.  Effect of inhaled prostaglandin E2 on allergen-induced asthma. , 1993, The American review of respiratory disease.

[28]  G. Baxter,et al.  In vitro characterization of prostanoid EP‐receptors in the non‐pregnant human myometrium , 1991, British journal of pharmacology.

[29]  P. Gardiner,et al.  Characteristics of prostaglandin induced cough in man. , 1985, British journal of clinical pharmacology.

[30]  N. C. Birkhead,et al.  Bronchodilator activity of a PGE2 analog in animals and in man. , 1981, Prostaglandins.

[31]  P. Eyre,et al.  Further studies of dog tracheobronchial smooth muscle. , 1980, Research communications in chemical pathology and pharmacology.

[32]  H. Collier,et al.  Effects of Prostaglandins on Human Bronchial Muscle , 1968, Nature.

[33]  H. Schild.  pAx and competitive drug antagonism. , 1949, British journal of pharmacology and chemotherapy.

[34]  S. Narumiya,et al.  Prostaglandin E2 is required for ultraviolet B-induced skin inflammation via EP2 and EP4 receptors , 2007, Laboratory Investigation.

[35]  E. Daniel,et al.  Neural and myogenic effects of cyclooxygenase products on canine bronchial smooth muscle. , 1995, The American journal of physiology.

[36]  P. Hedqvist,et al.  Effect of prostaglandins F2 alpha and E2 on airway conductance in healthy subjects and asthmatic patients. , 1975, The American review of respiratory disease.